Derangements of protein metabolism in chronic renal failure?

Blood Purification

Volumn 14, Issue 5, 1996, Pages 373-381

  Kaysen, George A ^a   Rathore, Vijay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acidosis; Hyperparathyroidism; IGF I; Immunoglobulins; Insulin resistance; Pancreatitis; Protein catabolism; Protein secretion; Protein synthesis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALANINE; ALBUMIN; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; CALCITRIOL; CALCIUM; ESSENTIAL AMINO ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; GROWTH HORMONE; IMMUNOGLOBULIN; INSULIN; MUSCLE PROTEIN; PROTEASOME; SOMATOMEDIN C; UBIQUINONE;

AMMONIA FORMATION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; GROWTH RETARDATION; HEMATOCRIT; HUMAN; HYPERPARATHYROIDISM; IMMUNOGLOBULIN PRODUCTION; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY PROXIMAL TUBULE; LIVER; METABOLIC ACIDOSIS; METABOLIC DISORDER; NONHUMAN; OXIDATION; PLASMA VOLUME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; T LYMPHOCYTE;

HUMANS; IMMUNOGLOBULINS; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LIVER; MUSCLE PROTEINS; MUSCLE, SKELETAL; PANCREAS; PROTEINS;

EID: 0029741092     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000170289     Document Type: Article

References (68)

1. Maack T: Renal handlingoflow molecular weight proteins. Am J Med 1975;58:57-64.
2. Moglielnicki RP. Waldtnann TA. Strober W: Renal handling of low molecular weight proteins. I. L-Chain metabolism in experimental renal disease. J Clin Invest 1971:50: 901-909.
3. Kaysen GA. Myers BD. Couser WG, Rabkin R, Felts JM: Mechanisms and consequences of proteinuria. Lab Invest 1986:54:479-498.
4. Mitch WE. Jurkovitz C. England BK: Mechanisms that cause protein and amino acid catabolism in uremia. Am J Kidney Dis 1993:21:91-95.
5. Mitch WE. Medina R. Gricber S. May RC. England BK. Price SR. Bailey JL. Goldberg AL: Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and protéasomes. J Clin Invest 1994:93:2127-2133.
6. Greibcr S, Mitch WE: Mechanisms for protein catabolism in uremia: Metabolic acidosis and activation of proteolytic pathways. Miner Electrolyte Metab 1992:18:233-236
7. Mitch WE, Chesney RW: Amino acid metabolism by the kidney. Miner Electrolyte Metab 1983:9: 190-202.
8. Pitts RF: Production and excretion of ammonia in relation to acid-base regulation; in Orloff J (ed): Handbook of Physiology/Renal Physiology. Washington, American Physiological Society, 1973, sect 8, pp 455-496.
9. Garibotto G. Russo R. Sala MR, Ancarani P. Robaudo C, Sofia A. Deferrari G, Tizianello A: Muscle protein turnover and amino acid metabolism in patients with chronic renal failure. Miner Electrolyte Metab 1992;18:217-221.
10. Reaich D., Graham KA., Channon SM, Hcthcrington C, Scrimgeour CM., Wilkinson R., Goodship TH: Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 1995;268:E121—El 26.
11. Castellino P., Solini A., Luzi L., Barr JG., Smith DJ, Pctridcs A., Giordano M., Carroll C, DeFronzo RA: Glucose and amino acid metabolism in chronic renal failure: Effect of insulin and amino acids. Am J Physiol 1992;262:F168-F176.
12. Blum WF: Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: Evidence for reduced secretion of IGFs. Acta Paediatr Scand 1991:379 (suppl):24-31.
13. Loughna PT., Mason P., Bales PC: Regulation of insulin-like growth factor 1 gene expression in skeletal muscle. Symp Soc Exp Biol 1992:46: 319-330.
14. Lowe WE Jr. Lasky SR, LeRoith D, Roberts CT Jr.: Distribution and regulation of rat insulin-like growth factor 1 messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver. Mol Endocrinol 1988;2:528-535.
15. Chan W, Kristoffer CV, Chan JCM: Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake. Kidney Int 1993:43:790-795.
16. Frystyk J., Skjacrback C, Dincscn B., Orskov H: Free insulin-like growth factor (IGF-I and IGF-11) in human serum. FEBS Lett 1994;348:185-191.
17. Mak RH., Haycock GB, Chantier C: Glucose intolerance in children with chronic renal failure. Kidney Int (suppl): 1983; 15:S22—S26.
18. Clark AS., Mitch WE: Muscle protein turnover and glucose uptake in acutely uremic rats. Effects of insulin and the duration of renal insufficiency. J Clin Invest 1983;72:836-845.
19. Beaumont JE, Rees ED, Luke RG: Insulin resistance in uremia: Amino acid metabolism. Nephron 1977; 19: 322-327.
20. Ricanati ES. Tsemg KY. Kalhan SC: Glucose metabolism in chronic renal failure: Adaptive responses to continuous glucose infusion. Kidney Int 1983:16 (suppl): 121-127.
21. Bak JF, Schmitz O. Sorensen SS. Frokjaer J. Kjaer T, Pedersen O: Activity of insulin receptor kinase and glycogen synthase in skeletal muscle from patients with chronic renal failure. Acta Endocrinol 1989:121: 744-750.
22. Oh HY., Fadda GZ., Smogorzewski M., Liou HH, Massry SG: Abnormal leucine-induced insulin secretion in chronic renal failure. Am J Physiol. 1994;267:F853-F860.
23. Kaysen GA, Majumdar APN, Du-bick MA, Vesenka GD. Mar G, Geokas MC: Biochemical changes in the pancreas of rats with chronic renal failure. Am J Physiol 1985: 249:F518-F523.
24. Lcrch MM. Hoppc-Seyler P. Gerok W: Origin and development of exocrine pancreatic insufficiency in experimental renal failure. Gut 1994; 35:401-407.
25. Gaciong Z., Alcxiewicz JM, Massry SG: Impaired in vivo antibody production in CRF rats: Role of secondary hyperparathyroidism. Kidney Int 1991;40:862-867.
26. Klinger M, Alcxiewicz JM. Linker-Israeli M. Pitts TO. Gaciong Z, Fadda GZ, Massry SG: Effect of parathyroid hormone on human T cell activation. Kidney Int 1990:37: 1543-1551.
27. Alexiewicz JA. Klinger M, Pitts TO, Gaciong Z, Linker-Israeli M, Massry SG: Parathyroid hormone inhibits B cell proliferation: Implications in chronic renal failure. J Am Soc Nephrol 1990;1:236-244.
28. Gaciong, Z, Alexiewicz, JA. Linker-Israeli M. Schulman IA. Pitts TO. Massry SG: Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure. Kidney Int 1991:40: 96-106.
29. Fadda GZ, Hajjar SM., Perna AF., Zhou X-J., Lipson LG., Massry SG: On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 1991:87:255-261.
30. Mak RFI: Insulin secretion in uremia: Effect of parathyroid hormone and vitamin D metabolites. Kidney Int 1989(suppl):27:227-230.
31. Mak RH: Carbohydrate metabolism in uremia. Pediatr Nephrol 1989,3: 201-208.
32. Allegra V, Luisetto G. Mengozzi G, Martimbianco L. Vasilc A: Glucose-induced insulin secretion in uremia: Role of lu,25(HO)2-vitamin Dj. Nephron 1994:68:41-47.
33. Kautzky-Willer A, Pacini G, Bamas U. Ludvik B. Streli C. Graf H. Prager R: Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995:47:200-206.
34. Padilla B, Poliak VE, Pesce A. Kant KS. Gilinsky NIL Deddens JA: Pancreatitis in patients with end-stage renal disease. Medicine 1994:73:8-20.
35. Vaziri ND. Dure-Smith B. Miller R. Mirahmadi M: Pancreatic pathology in chronic dialysis patients: An autopsy study of 78 cases. Nephron 1987;46:347-349.
36. de Koning EJ, Fleming KA., Gray DW., Clark A: High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment. J Pathol 1995:175: 253-258.
37. Zern MA., Yap SH., Strair RK, Kayscn GA., Shafritz DA: The effects of chronic renal failure on protein synthesis and albumin mRNA in rat liver. J Clin Invest 1984:73:1167-1174.
38. Kaysen GA. Watson JB: Mechanism of hypoalbuminemia in the 7/8 nephrectomizcd rat with chronic renal failure. Am J Physiol 1982; F372-F378.
39. Kaysen GA. Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25:107-114
40. Yokozawa T, Yasui T. Ishii S, Oura H: Decrease in the level of albumin mRNA with progression of renal failure in rats. Nippon Jinzo Gakkai Shi 1994;36:317-321.
41. Blumcnkrantz MJ, Kopplc JD. Gutman RA. Chan YK, Barbour GL, Roberts C, Schen GH. Gandi VC. Tucker CT. Curtis FK, Coburn JW: Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 1980,33:1567-1585.
42. Schoenfeld PY, Henry RR, Laird NM., Roxe DM: Assessment of nutritional status of the national cooperative dialysis study population. Kidney Int 23(suppl 13):80—88.
43. Aechiardo SR, Moore LW, Latour AP: Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 24(suppl 16): 199-203.
44. Jensen H, Rossing N, Anderson SB. Jarnum S: Albumin metabolism in the nephrotic syndrome in adults. ClinSci 1967:33:445-457.
45. Moshagc HJ, Janssen JAM., Frans-sen JH., Hafkenscheid JCM., Yap SH: Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987;79:1635-1641.
46. Koj A. Gauldie J. Sweeney GD, Re-goeezi E, Saudcr DN: A simple bioassay for monocyte-derived hépatocyte stimulating factor: Increased synthesis of otj-macroglobu-lin and reduced synthesis of albumin by cultured rat hépatocytes. J Immunol Methods 1985:76:317-327.
47. Kaysen GA, Rathore V, Shearer GC, Depner TA: Meehan isms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995;48:510-517.
48. Attman P-O, Alaupovic P, Gustafson A: Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 1987;32:368-375.
49. Fuh MMT, Lee C-M, Jeng C-Y. Shen D-C, Shich S-M, Reavcn GM. Chen Y-DI: Effect of CRF on high-density lipoprotein kinetics. Kidnev Int 1990;37:1295-1300.
50. Glass CK, Pittman RC, Keller GA, Steinberg D: Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 1983;258:7161-7167.
51. Kostncr GM, Avogaro P., Cazzolato G, et al: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981:38:51-61.
52. Utermann G: The mysteries of lipo-protein(a). Science 1989:246:904-910.
53. Boerwinkle E, Menzel HJ, Kraft HG., Utermann G: Genetics of the quantitative Lp(a) lipoprotein trait. 111. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989, 82:73-78.
54. Gavish D, Azrolan N, Breslow J: Plasma Lp(a) concentration is inversely correlated with the ratio of kringle IV/kringle V encoding domains in the apo(a) gene. J Clin Invest 1989:84:2021-2027.
55. Guillausseau P-J. Pcynet J. Chanson P. Legrand A, Altman J-J, Poupon J. N'Guyen M. Rousselct F. Lubetzki J: Lipoprotein (a) in diabetic patients with and without chronic renal failure. Diabetes Care 1992:15: 976-979.
56. Kaysen GA: Hyperlipidemia of chronic renal failure. Blood Purif 1994;12:60-67.
57. Lindgren SC, Laurcll CB, Sterner GN: Plasma protein homeostasis in chronic hemodialysis patients. Scand J Urol Nephrol 1992:26:279-282.
58. Floegc J, Wilks MF, Soose M, Kot-zerke J. Shaldon S, Koch KM: Renal elimination of pi-microglobulin and myoglobin in patients with normal and impaired renal function. Nephron 1990;55:361-367.
59. Cunningham BA, Wang JL., Berg-gárd I, Peterson PA: The complete amino acid sequence of P;-microglo-bulin. Biochemistry 1973; 12:4811 -4822.
60. Creswell P. Springer T, Stromingcr JL, Turner MJ, Grey HM, Kubo RT: Immunological identity of the small subunit of HLA antigens and p2-microglobulin and its turnover on the cell membrane. Proc Natl Acad Sci USA 1974:71:2123-2207.
61. Girevuc OD, Casey TT, Stone WJ, DiRaimondo CR, Prclli FC, Fran-gione B: Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985;76:2425-2429.
62. Vandenbrouckc JM, Jadoul M., Mal-daguc B, Huaux JP, Noel H., van Ypcrsele de Strihou C: Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet 1986:vol ii: 1210—1211.
63. McCarthy JT, Williams AW, Johnson WJ: Scrum pj-microglobulin concentration in dialysis patients: Importance of intrinsic renal function. J Lab Clin Med 1994:123:495-505.
64. Risler T. Braun N, Hand KD, Kuhl-mann U, Skroch D. Muller GA: Do different dialysis-membranes affect beta-2-mícroglobulin kinetics during chronic hemodialysis? Int J Artif Organs 1994;17:581-584.
65. Maiorca R., Cancarini GC, Brunori G, Camerini C., Manili L: Morbidity and mortality of CAPD and hemodialysis. Kidney Int 1993:40: (suppl):4-15.
66. Amici G, Virga G. Da Rin G. Gran-desso S. Viancllo A, Gatti P. Bocci C: Serum pi-microglobulin level and residual renal function in peritoneal dialysis. Nephron 1993:65:469-471.
67. Tsianos EV. Dardamanis MA, Eli-saf M, Vasakos S, Siamopoulos KC: The value of alpha-amyiase and isoamylase determination in chronic renal failure patients. Int J Pancrcatol, 1994:15:105-111.
68. Buchman AL, Ament ME, Moukar-zel A: Total serum amylase but not lipase correlates with measured glomerular filtration rate. J Clin Gastroenterol 1993;16:204-206.